Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Associated Press

Earlier this week the WHO reported there have now been more than 500,000 cases of cholera in Yemen since April — making it one of the world's largest and fastest growing epidemics of the diarrheal disease to date.

Yes, but: In July, the organization made a surprising announcement that it wasn't moving forward with plans to begin administering half a million doses of cholera vaccine that were standing by for delivery, saying it would be ineffective given the security situation in the country and the epidemic's rapid escalation. Instead they intend to focus on improving sanitation and access to clean water and treatment.

Expert opinion: I spoke with cholera experts who have been involved in vaccination campaigns around the world. All noted they haven't worked in Yemen but from a global perspective are concerned the current plan in the country doesn't reflect what's known about the vaccine's effectiveness, and could perpetuate a belief that vaccinating people in the midst of an epidemic won't have an impact.

Two beliefs:

Once an epidemic is underway, vaccinating won't have an impact.

  • "It's misguided," says David Sack of Johns Hopkins who chairs a task force on oral cholera vaccine (which WHO participates in). "The fact that it wasn't given earlier isn't a reason to give it whenever you get it."
  • Andrew Azman, also from Hopkins but based in Malawi, points to the success of using the Shachol vaccine in the midst of a 2012 outbreak in Guinea to stop transmission.
  • Modeling by Azman and his colleagues found evidence that single doses of vaccine can afford some short-term protection against infection.
  • "Obviously you have the biggest impact if you vaccinate before an epidemic or at the earliest stages but you can still avert plenty of cases and plenty of deaths well after the peak of an epidemic."

It is only effective to vaccinate people who haven't been infected with the disease.

  • Louise Ivers, who has led Partners In Health's cholera vaccine efforts in Haiti, where a seven-year epidemic of cholera rages on, says there is no harm in vaccinating people who are already exposed to cholera or have natural immunity to it.
  • Its less efficient to vaccinate large numbers of people who have already been infected, but vaccinating some in the interest of protecting all those that are still at risk is worthwhile, Ivers said.

WHO spokesperson Gregory Härtl: "If you can "blanket" vaccine coverage before people are infected, they will not get infected, thus reducing the number of people who can spread the disease, whereas if you try to vaccinate once the cholera outbreak is in full swing, the number of people already infected and able to transmit the disease is already so great that the effectiveness of (scarce) vaccine is greatly diminished."

The vaccine: One of the least expensive and widely used — Shachol— is $1.85 per dose and requires limited health training to be delivered orally. A recent summary of studies found cholera vaccines are 76% effective in the field.

Ivers: "Water and sanitation have been the way we historically deal with cholera. But in Europe, thousands of people died over the decades it took us to build infrastructure... It's very hard to immediately deliver clean water to thousands or millions of people. Vaccine is the bridge. We know it works."

Sack: "I'm sympathetic to the difficulties in providing vaccine but the idea that they are going to improve sanitation when they can't give a simple oral vaccine flies in the face of reality... This is often thought of as a dichotomy — vaccines or sanitation. These are not opposing options. They need to be integrated."

The bottom line: Cholera is a global disease increasingly affecting people, especially those living in poverty and conflict, around the world. "It is 100% preventable and 100% treatable. No one should die of diarrhea," said Ivers.

Go deeper

Rep. Rice demands Cuomo resign after third woman accuses him of misconduct

New York Gov. Andrew Cuomo during a February news conference in New York City. Photo: Seth Wenig/POOL/AFP via Getty Images

Rep. Kathleen Rice (D-N.Y.) on Monday evening called for New York Gov. Andrew Cuomo (D) to resign, after a third woman accused him of inappropriate behavior.

Driving the news: Anna Ruch told the New York Times Monday that Cuomo asked to kiss her at a New York City wedding reception in September 2019.

Scoop: Inside the GOP's plan to retake the House

House Minority Leader Kevin McCarthy. Photo: Elijah Nouvelage/Bloomberg via Getty Images

House Republicans will reclaim their majority in 2022 by offering candidates who are women, minorities or veterans, a memo obtained by Axios says.

Why it matters: The document, drafted by a super PAC blessed by House Minority Leader Kevin McCarthy, names top Democrats to target — Jared Golden of Maine, Matt Cartwright of Pennsylvania and Ron Kind of Wisconsin — and the type of Republican candidates to beat them.

53 mins ago - Politics & Policy

Scoop: Trump talked out of early Ohio endorsement

Jane Timken at a 2017 Trump rally. Photo: Kyle Mazza/NurPhoto via Getty Images

Donald Trump had to be talked out of making an early endorsement in Ohio's 2022 U.S. Senate race, a sign of his eagerness to reengage politically, people familiar with the conversations tell Axios.

What we're hearing: The former president discussed endorsing former state GOP chair Jane Timken last week during a meeting at Mar-a-Lago with RNC Chairwoman Ronna McDaniel, but top advisers — including Donald Trump Jr. — urged him to wait.